IndraLab

Statements

JOSD2 activates glycolytic process. 1 / 1

| 1

eidos

"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non-small cell lung cancer ."

33082514

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

JOSD2 activates glycolytic process. 1 / 1

INDRA sources:

Databases

Reading